PMS and diabetes share many physical and psychological symptoms, but what is the relationship between the two, and could anti-diabetic drugs have a favorable impact on the symptoms of PMS?
A range of effective medical and non-medical interventions are available for treating peripheral artery disease, so why are major adverse cardiovascular and limb outcomes still so prevalent?
SGLT2 inhibitors may reduce the risk for dialysis, heart failure and myocardial infarction in patients with type 2 diabetes and stage 5 chronic kidney disease.
EIAS can cause hyperglycemia, hypoglycemia, and ketoacidosis in people with diabetes. This case in an older adult with type 1 diabetes shows how EIAS can be managed in an outpatient setting.
Our tailored content service will keep you up to date…
Receive newsletters curated for the busy specialist by our expert editorial team
EIAS can cause hyperglycemia, hypoglycemia, and ketoacidosis in people with diabetes. This case in an older adult with type 1 diabetes shows how EIAS can be managed in an outpatient setting.
Intermittently scanning CGM detected hypoglycemia in a woman previously diagnosed with schizophrenia and treated with antipsychotic medication. Insulinoma was diagnosed and resected, resolving her neuropsychiatric symptoms.
Rapidly progressive insulin-dependent diabetes in the absence of islet autoantibodies developed 2 years after starting treatment with the immune checkpoint inhibitor nivolumab.
With the growing importance of primary care in diabetes, this podcast discusses the evidence on continuous glucose monitoring (CGM) use, the role of primary healthcare, and practical tips for interpreting the ambulatory glucose profile (AGP) report.
Tirzepatide is a novel antidiabetic medication a single-molecule, agonist to the glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors. It is approved in the USA and EU for the treatment of type 2 diabetes mellitus …
The Oral Glucose Tolerance Test (OGTT) remains a gold standard for diagnosis of diabetes and prediabetes all over the world and also in India. The original OGTT was a five sample test which included fasting, 30, 60, 90, and 120 min. Later, the …
This article is a continuation of Part 1 where we discussed insulin resistance as the primary driver of medical obesity and the cardiometabolic sequelae. Insulin resistance has two essential components. The first is the insulin resistance itself …
Pediatric obesity rates and weight-related comorbidities continue to rise despite increasing awareness. Nationally, the obesity rates among 20–39-year-olds is approximately 40%, as reported by the CDC [ 1 ]; this is a 300% increase since the 1970s …
Despite many recent advances in its management, type 1 diabetes remains a burden for those living with the condition.
Prof. Chantal Mathieu explains the progress being made with disease-modifying therapy for type 1 diabetes and how it has the potential to transform the current treatment landscape.
Stay up to date with the rapidly changing CGM landscape. Learn how to implement and integrate CGM into diabetes management to improve patient care and outcomes.
Expert guidance on the multidisciplinary approach to identifying and managing chronic kidney disease in patients with type 2 diabetes, plus patient scenarios to assist your decision-making and put the latest clinical guidelines into context.
This program is not available to users in the UK and US.
An independent educational program featuring simulated patient consultations. Make knowledge-based decisions on diagnosis and management of CKD with and without co-morbidities, and learn from experts Kevin Fernando and David Wheeler.
Diabetes mellitus affects one in ten Americans, with 90‒95% of patients with diabetes diagnosed with type 2 diabetes mellitus (T2DM) [ 1 ]. T2DM rarely occurs on its own and is typically associated with a host of comorbid conditions. Comorbidities …
Impaired renal function is a common long-term complication of diabetes mellitus as up to 40% of individuals with diabetes develop chronic kidney disease [ 1 , 2 ]. It is well known that renal impairment can alter drug pharmacokinetics, potentially …
Defensins are small molecules (2–5 kDa) that play an important role in the innate and adaptive defence system. They belong to a large family of antimicrobial peptides of ancient conservation. Humans express two subfamilies, Alpha- and …
PMS and diabetes share many physical and psychological symptoms, but what is the relationship between the two, and could anti-diabetic drugs have a favorable impact on the symptoms of PMS?
PMS and diabetes share many physical and psychological symptoms, but what is the relationship between the two, and could anti-diabetic drugs have a favorable impact on the symptoms of PMS?
SGLT2 inhibitors may reduce the risk for dialysis, heart failure and myocardial infarction in patients with type 2 diabetes and stage 5 chronic kidney disease.
EIAS can cause hyperglycemia, hypoglycemia, and ketoacidosis in people with diabetes. This case in an older adult with type 1 diabetes shows how EIAS can be managed in an outpatient setting.
